Project Details
Description
Project Narrative
This proposal addresses a novel direction in lupus pathogenesis in that following
exposure to a lupus trigger with loss of tolerance, inherent pre-existing defects in CD4
IL-2 production skew towards autoantibody production and away from a beneficial cell
mediated immune response that could restore tolerance. Using a mouse model of
induced lupus, we will map the genes that predispose to severe lupus and to reduced IL-
2 production. Identification of these genes will advance the possibility of not only
prospectively identifying humans at risk for severe lupus but also which patients are
likely to benefit from low dose IL-2 treatment.
| Status | Finished |
|---|---|
| Effective start/end date | 1/02/20 → 31/01/23 |
Funding
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES: $190,621.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.